Aurobindo Pharma Limited
AUROPHARMA
Classement en actions
#2066
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Prix de l'action
$17.29
Capitalisation boursière
$9.95B
Changement (1 jour)
-3.38%
Changement (1 an)
38.28%
Pays
IN
Échange Aurobindo Pharma Limited (AUROPHARMA)
Catégorie
Healthcare
EPS pour Aurobindo Pharma Limited (AUROPHARMA)
EPS au June 2026 TTM : $0.71
Selon les derniers rapports financiers et le cours de l'action de Aurobindo Pharma Limited, l’EPS actuel de la société (TTM) est de $0.71. À la fin de 2024, la société avait un EPS de $0.65 une augmentation par rapport à celui de 2023, qui était de $0.40.
Historique de l'EPS de Aurobindo Pharma Limited de 2004 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2026 (TTM) | $0.71 | 0.90% |
| 2025 | $0.70 | 7.68% |
| 2024 | $0.65 | 62.23% |
| 2023 | $0.40 | -32.77% |
| 2022 | $0.60 | -52.13% |
| 2021 | $1.24 | 92.96% |
| 2020 | $0.64 | 10.91% |
| 2019 | $0.58 | -8.50% |
| 2018 | $0.64 | 4.73% |
| 2017 | $0.61 | 15.90% |
| 2016 | $0.52 | 20.94% |
| 2015 | $0.43 | -3.95% |
| 2014 | $0.45 | 384.93% |
| 2013 | $0.09 | -322.25% |
| 2012 | $-0.04 | -119.03% |
| 2011 | $0.22 | -5.22% |
| 2010 | $0.23 | 529.89% |
| 2009 | $0.04 | -66.91% |
| 2008 | $0.11 | 27.82% |
| 2007 | $0.09 | 190.97% |
| 2006 | $0.03 | 1,893.33% |
| 2005 | 0.00 | -97.13% |
| 2004 | $0.05 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -21.24% |
IN
|
